LEO Pharma and its Boston-based R&D innovation unit LEO Science & Tech Hub, and Advancing Innovation in Dermatology (AID) announced today that LEO and AID will each contribute $500,000 into the recently created Advancing Innovation in Dermatology Accelerator Fund.
The accelerator will provide economic and intellectual capital to further a discovery’s potential for commercialization
Dec 11, 2018
Medical societies can support innovation
Oct 05, 2018
A critical first step to defining great problems
Sep 11, 2018
Innovation matters in dermatology